Pharmacopsychiatry

Improving medication effects in hard-to-treat depression using sleep deprivation combined with earlier sleep timing

Updated

Abstract

Ten out of 21 participants showed a response to treatment with a reduction of ≥50% in depression symptoms by day 14.

  • Total sleep deprivation (TSD) combined with sleep phase advance (SPA) may enhance the effects of existing antidepressant treatments in patients with treatment-resistant depression (TRD).
  • Responders had lower baseline cortisol levels compared to non-responders, suggesting a potential association between cortisol and treatment response.
  • Cortisol levels decreased during the treatment period in both responders and non-responders.
  • An increase in the levels of interleukin-10 (IL-10) and IL-1β was observed in responders by day 14, indicating a possible link between these biochemical markers and clinical improvement.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors declare no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free